EV/EBITDA - Mabwell Shanghai Bioscience Co Ltd (SSE:688062) - Alpha Spread
M

Mabwell Shanghai Bioscience Co Ltd
SSE:688062

Watchlist Manager
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Watchlist
Price: 21.24 CNY -0.28% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Mabwell Shanghai Bioscience Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

-7.8
Current
-8.2
Median
5.1
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-7.8
=
Enterprise Value
8.1B CNY
/
EBITDA
-1B CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-9.3
2-Years Forward
EV/EBITDA
-9.4
3-Years Forward
EV/EBITDA
7 977.1

See Also

Discover More